T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.4% |
| 2 | Healthcare | 16.1% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
QuantumScape Corp
QS
$3.82B
| $2.52M | ﹤0.01% |
113,564
+30,833
| +37% | +$845K |
|
|
JHG
1627
DELISTED
Janus Henderson
JHG
| $2.5M | ﹤0.01% |
59,591
-2,882
| -5% | -$127K |
|
1628
Encompass Health
EHC
$12.2B
| $2.48M | ﹤0.01% |
47,709
+719
| +2% | +$37.1K |
|
1629
Agree Realty
ADC
$9.36B
| $2.48M | ﹤0.01% |
34,698
-500
| -1% | -$34.7K |
|
1630
Urban Edge Properties
UE
$2.78B
| $2.46M | ﹤0.01% |
129,648
-2,013
| -2% | -$36.9K |
|
1631
Commerce Bancshares
CBSH
$8.67B
| $2.46M | ﹤0.01% |
43,460
-13,776
| -24% | -$775K |
|
|
TPH
1632
DELISTED
Tri Pointe Homes
TPH
| $2.45M | ﹤0.01% |
87,980
+2,506
| +3% | +$63K |
|
1633
LXP Industrial Trust
LXP
$3.57B
| $2.45M | ﹤0.01% |
31,395
-1,392
| -4% | -$103K |
|
1634
Brown-Forman Class A
BF.A
$13.3B
| $2.44M | ﹤0.01% |
36,000
| – | – |
|
1635
iShares Core US Aggregate Bond ETF
AGG
$138B
| $2.43M | ﹤0.01% |
+21,326
| New | +$2.44M |
|
1636
Liberty Broadband Class A
LBRDA
$5.27B
| $2.43M | ﹤0.01% |
15,091
+250
| +2% | +$40.5K |
|
1637
BOK Financial
BOKF
$8.87B
| $2.43M | ﹤0.01% |
22,999
-56
| -0.2% | -$5.75K |
|
1638
CNO Financial Group
CNO
$5.12B
| $2.43M | ﹤0.01% |
101,780
-2,334
| -2% | -$57.3K |
|
1639
Copa Holdings
CPA
$6.18B
| $2.41M | ﹤0.01% |
29,143
-7,690
| -21% | -$603K |
|
1640
Acuity Brands
AYI
$10.7B
| $2.41M | ﹤0.01% |
11,367
-925
| -8% | -$191K |
|
1641
WesBanco
WSBC
$4.12B
| $2.4M | ﹤0.01% |
68,482
-4,388
| -6% | -$154K |
|
1642
Fulcrum Therapeutics
FULC
$286M
| $2.38M | ﹤0.01% |
134,755
+90,355
| +204% | +$1.79M |
|
|
SAIL
1643
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $2.38M | ﹤0.01% |
49,277
+7,408
| +18% | +$363K |
|
1644
Brixmor Property Group
BRX
$9.23B
| $2.38M | ﹤0.01% |
93,519
-4,838
| -5% | -$116K |
|
1645
LivaNova
LIVN
$4.46B
| $2.38M | ﹤0.01% |
27,174
-890
| -3% | -$74.2K |
|
1646
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $2.38M | ﹤0.01% |
27,760
-1,500
| -5% | -$129K |
|
1647
Vertiv
VRT
$112B
| $2.37M | ﹤0.01% |
95,040
-452
| -0.5% | -$11.3K |
|
|
ALLK
1648
DELISTED
Allakos
ALLK
| $2.37M | ﹤0.01% |
242,137
+226,340
| +1,433% | +$18.5M |
|
1649
Sonoco
SON
$5.74B
| $2.36M | ﹤0.01% |
40,756
-1,515
| -4% | -$90.5K |
|
1650
AGNC Investment
AGNC
$13B
| $2.35M | ﹤0.01% |
156,059
-31,815
| -17% | -$504K |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.